chrisvoncsefalvay/vaers-outcomes huggingface dataset:
facial swelling especially around the eyes with red blotches including on the neck / 1st:Solumedral, Benadryl, Pepcid, IV hydration helped with the swelling but did not cure / 2nd: Kenalog injection, Kenalog 0.1% cream twice daily received 08/08/21 with some improvement shown
Not sure if related to vaccine but I just wanted to inform the CDC in case it is an adverse event from the Pfizer vaccine. I received my second dose on Feb. 10th, 2021 and began showing elevated blood glucose levels later in February. By the end of May, I was showing symptoms of diabetes, including frequent urination, extreme thirst, and neuropathy. I went to the hospital on June 21st, 2021 after passing out at work and was diagnosed with diabetic ketoacidosis and Type 1 Diabetes.
Swollen, redness, burning and itching at injection site for over 2 days. Nausea, body aches, lightheadedness and extreme fatigue.
Reported general malaise.  Had blister pop up that ran from the opening of the left nare and continued to space between upper lip and nose. Itching all over, especially in head.  Blisters on sides of tongue.
pt had a positive COVID test in SNF on 7/4/22; pt brought to ED via EMS with decreased UOP, AKI, low BP, increased confusion; pt's condition continued to deteriorate requiring intubation; suffered cardiac arrest; CPR done; pt has permanent pacemaker; husband decided on comfort care and pt passed away in the hospital
This initial non-serious spontaneous case was received on 21-Sep-2017 from other non-health professional, concerning a female patient of unspecified age. The patient's medical history and concomitant medications were not reported. On an unspecified date (reported as last year), the patient was administered with influenza vaccine (dose, route of administration, anatomical location, batch number, expiry date, trade name, manufacturer: not reported). On an unspecified date, the patient experienced swelling in her throat and mouth after vaccination. It was reported that the reaction was due to the preservative used in vaccine and the patient had recovered from the events.
I got my 2nd shot on March 26th.  On Monday March 29th 6:00pm, my elbows started to itch and develop hives/rashes.  Then my knees and then foot and hands by the night.  It was burning and itching and it swelled up a little. Oddly the itchiness and redness goes away and then comes.  Taking Allegra does help but its not making the symptoms go away.
Extreme fatigue, overall body soreness, finger joint swelling and pain, metallic taste in mouth, some mild chest tightness.
Woke up vomiting. Continued until mid morning.  Called ambulanced and went to ER
Lose sensation in my fingers and toes/ lack of sensation has spread throughout my entire body; Severe cramping happens sporadically, primarily in my hands, feet and legs; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 44-year-old male patient received BNT162b2 (BNT162B2), on 16Jun2021 at 14:00 as dose 2, single (Lot number: EW0178) at the age of 44 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. The patient took concomitant medications. Vaccination history included: BNT162b2 (Dose Number: 1, Batch/Lot No: EW0185, Location of injection: Arm Left, Vaccine Administration Time: 02:00 PM), administration date: 22May2021, when the patient was 44-year-old, for Covid-19 immunization. The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not tested for COVID-19. The following information was reported: SENSORY LOSS (disability) with onset 02Jul2021, outcome "not recovered", described as "Lose sensation in my fingers and toes/ lack of sensation has spread throughout my entire body"; MUSCLE SPASMS (disability) with onset 02Jul2021, outcome "not recovered", described as "Severe cramping happens sporadically, primarily in my hands, feet and legs". The events "lose sensation in my fingers and toes/ lack of sensation has spread throughout my entire body" and "severe cramping happens sporadically, primarily in my hands, feet and legs" required physician office visit. The patient underwent the following laboratory tests and procedures: Blood test: Okay; Computerised tomogram abdomen: Unremarkable; Computerised tomogram pelvis: Unremarkable; Computerised tomogram thorax: Unremarkable; Electromyogram: Unremarkable; Fat Aspirate Procedure: Unknown results; Lumbar puncture: Unremarkable; Magnetic resonance imaging head: Unknown results; Good; Magnetic resonance imaging neck: Good; Oxygen saturation: Unknown results; Reflex test: Unknown results; Sweat test: Unknown results; Ultrasound testes: Unknown results. Therapeutic measures were not taken as a result of sensory loss, muscle spasms. Clinical course: A few weeks after receiving the 2nd dose, patient started to lose sensation in his fingers and toes. Since then, the lack of sensation had spread throughout his entire body. In addition, severe cramping happens sporadically, primarily in his hands, feet and legs. Patient have seen a Neurologist, Autoimmune Specialist and a Urologist.   No follow-up attempts are possible. No further information is expected.
complaining of a mild headache, cough, nasal congestion and sinus pressure since Sunday morning.  Also states that her ears hurt.  She did watch her grandchild who is 13 years old and had the same signs and symptoms that she has and her grandchild's Covid test was negative.  Patient's Covid test today is positive.  Review of Symptoms:   Review of Systems  Constitutional: Negative for chills and fever.  HENT: Positive for congestion, ear pain and sinus pressure. Negative for ear discharge, hearing loss and sore throat.   Respiratory: Positive for cough. Negative for shortness of breath and wheezing.   Cardiovascular: Negative for chest pain and palpitations.  Gastrointestinal: Negative for abdominal pain, blood in stool, diarrhea, nausea and vomiting.  Genitourinary: Negative for dysuria and urgency.  Skin: Negative for rash.  Neurological: Positive for headaches.  Head: Normocephalic.     Right Ear: Hearing normal. Tympanic membrane is injected.     Left Ear: Hearing and tympanic membrane normal.   Nose: Congestion and rhinorrhea present. No mucosal edema.     Right Sinus: Maxillary sinus tenderness and frontal sinus tenderness present.     Left Sinus: Maxillary sinus tenderness and frontal sinus tenderness present.  Lungs clear and equal bilaterally, no respiratory distress, does have a cough
The patient jerked downwards from the needle, resulting in a subdermal prick and bending the needle. That needle was null and void. The majority of vaccine 'dispersed' on the outside of the arm.
Pt presented to the ED presented to Hospital on 02/26/2022 for abdominal pain, vomiting and diarrhea. CT abdomen/pelvis consistent with acute pancreatitis with possible small gallstones/gallbladder sludge.Chest x-ray negative for any acute cardiopulmonary process. EKG showed normal sinus rhythm without any acute ST-T changes.  Pt was COVID positive. He was given IV fluids.  Remdesivir therapy was initiated. AST worsened to 119, likely secondary to Remdesivir.
At about 5 pm the same day of receiving the shot I started to break out in hives on my chest. Later that evening I started to feel numb from the neck down. I had a hard time walking. My whole body felt sore. I started to run a fever of 101.9. This lasted for about 24 hours.
Information has been received from a medical assistant referring to a 4 year old patient of unknown gender. Information about medical history, concurrent condition and concomitant medication was unknown. On 19-OCT-2018, the patient received an improperly stored dose of PROQUAD (lot # R012417, expiry date: 28-OCT-2019; dose, frequency and route were not reported) for prophylaxis (product storage error), which was reconstituted with properly stored sterile diluent. No adverse effects were reported. There was no previous temperature excursion. It was also reported that temperature was from 15 Fahrenheit to 46 Fahrenheit for 8 hours and the data logger was involved. Sender's Comments: US-009507513-1902USA007536: US-009507513-1901USA008772: US-009507513-1902USA007537: US-009507513-1902USA007539: US-009507513-1902USA007540: US-009507513-1902USA007541: US-009507513-1902USA007542: US-009507513-1902USA007543: US-009507513-1902USA007544: US-009507513-1902USA007545: US-009507513-1902USA007546: US-009507513-1902USA007547: US-009507513-1902USA007548: US-009507513-1902USA007549: US-009507513-1902USA007550.
Headache Flushed, fatigue, About 6.5 hours after the vaccine onset of exhaustion and headache. Co-workers told him he looked flushed. He's going home from work. 1/14 -  overnight had headache, arm pain, and achy. He stayed home on 1/14 because he was so achy in his joints. 1/15 - employee feels much better today and went back  to work. Back to normal.
This is a spontaneous report was received from a contactable physician (Patient). A 38-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 07Jan2021 as single dose for COVID-19 immunization. The patient had no other medical history, and the patient was not taking concomitant medications. There were no known allergies reported. The patient was not pregnant at the time of vaccination. On 07Jan2021, the patient experienced Immediate dizziness and tachycardia after the shot. 30 minutes after receiving the vaccine, throat itching, dizziness, abdominal cramps. As result of event patient was in Emergency room/department or urgent care. Patient did not receive any treatment for event. Patient did not receive any other vaccine in four weeks. It was not available whether the patient was taking other medications in two weeks. Patient did not have Covid prior vaccination. Patient did not test Covid post vaccination. The outcome of event was recovered on an unspecified date in 2021. Information on the lot/batch number has been requested. Follow-up (16Apr2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Constant crying for first 7 days, kept falling down when walking because of pain in leg; fever 103.6; light nosebleed. Reported all symptoms by phone to nurse on 12/6/0 at 9am, was told symptoms were normal. Nose bleed was from change in the weather. Large, red blisters broke ut on 12/14/02 on scalp, forehead, stomach and thighs. Took child to doctor for treatment on 12/19/02. Diagnosed on 12/19 as "possible" chicken pox; doctor said blister on scalp and face look like pox, as well a two puss-filled blisters on inner thighs.
1st dose date 01Mar2021 2nd dose date 08Apr2021; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose date 01Mar2021 2nd dose date 08Apr2021) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027B21A and 031A21A) for COVID-19 vaccination. No Medical History information was reported.On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose date 01Mar2021 2nd dose date 08Apr2021). On 08-Apr-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose date 01Mar2021 2nd dose date 08Apr2021) had resolved. No concomitant medications were reported.No treatment medications were reported.This case was linked to MOD-2021-388541 (Patient Link).
NERVOUS; DIZZINESS; WEAKNESS; COLD; FLU LIKE SYMPTOMS; SORE AT INJECTION SITE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 11-APR-2021 for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On APR-2021, the subject experienced sore at injection site. On 12-APR-2021, the subject experienced cold. On 12-APR-2021, the subject experienced flu like symptoms. On 17-APR-2021, the subject experienced nervous. On 17-APR-2021, the subject experienced dizziness. On 17-APR-2021, the subject experienced weakness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the nervous, cold, flu like symptoms, sore at injection site, dizziness and weakness was not reported. This report was non-serious.
Patient reports on 06/19/2018 she experienced severe headaches, muscle aches, and nausea. On 06/22/2018 she reports hip pain and limitation in range of motion. On 06/27/2018 she reports presentation of painful cold sores inside the mouth between the cheek and gums.
Right arm hives - from finger up to whole arm. Lasted 2 days per patient NO Hives on left arm where pt received Influenza HD. ONLY on right arm where she received Covid.
Vaccine administered Wed afternoon2/24. Hives/rash started on Friday morning  2/26.  Started on both arms and legs, and has progressed to abdomen, buttocks, lower back. Has continued to spread, and is now to feet. Severe in nature, painful and itchy.
Cough; muscle aches; joint pain; fatigue; headache; arm pain; This is a spontaneous report from a contactable physician (patient). A 38-year-old male patient received his second dose of BNT162B2 (lot number: EH2184), via an unspecified route of administration in the left arm on 07Jan2021 at 08:30 at single dose for Covid-19 immunization.  Medical history was none. The patient had no known allergies. There were no concomitant medications. The patient received his first dose of BNT162B2 (lot number: EH9899) in the left arm on 17Dec2020 at 09:00 for Covid-19 immunization. The patient had no other vaccine in four weeks nor other medications in two weeks. The patient experienced cough requiring albuterol (the patient had never had any history of reactive airway disease or bronchoconstriction), other post-vaccine symptoms included muscle aches, joint pain, fatigue, headache, and arm pain; all on 08Jan2021 at 20:00. The adverse events resulted in doctor or other healthcare professional office/clinic visit. The patient had no COVID prior vaccination nor tested with COVID post vaccination. The patient recovered from the events in Jan2021.
24 hours after vaccine swelling to throat and face, shortness of breath, dizziness, weakness, headaches-symptoms lasted 3 days
TC from MD office 29AUG96 states pt there w/severe local rxn of lt arm;
8 days post MMR, Varicella, PREVNAR, HepA pt with 2-3 seizures lasting 1 min each, tonic/clonic. No fever with 1st seizure, fever in ER 101.
Started with headache and soreness. And cramping and diarrhea . Concerned because still having these symptoms 5 days later and have now devolved dizziness and nausea.
Within one week in the middle of the night of my second moderna covid vax, I woke up with an extremely swollen, itchy and painful left breast.  My nipple was oozing a bronze fluid.   The itching continued and the nipple became painful as well.  I had had a routine mammogram March 12 2021 that was totally normal.  I initially for weeks just lived with the pain.  Then in July, I started to have terrible rashes on my hands and in the crook of my elbows.  In August of 2021, I finally saw my general NP and she sent me for another breast exam, then imaging and then a breast biopsy that all showed the same result: severe atopic dermatitis due to an adverse drug reaction.  started seeing a dermatologist after the biopsy, by now, the dermatitis has taken over my entire body.
Rash below injection site. Pain in elbow. Told pt to take BENADRYL and TYLENOL for pain and to call MD.
No additional AE reported; first dose in September 2021, second dose in November 2021, and third dose today; This spontaneous report was received from a physician referring to a 39-year-old male patient. The patient's pertinent medical history, drug reactions/allergies, concurrent conditions and concomitant medications were not reported.      On an unspecified date in September 2021, the patient was vaccinated with the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) 0.5 mL for prophylaxis (strength, dose, route of administration, lot # and expiration date were not reported).   On an unspecified date in November 2021, the patient was vaccinated with the second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) 0.5 mL for prophylaxis (strength, dose, route of administration, lot # and expiration date were not reported).   On an unspecified date in December 2021, the patient was vaccinated with the third dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) 0.5 mL for prophylaxis (strength, dose, route of administration, lot # and expiration date were not reported). No additional adverse event (AE) was reported.
Received 2nd dose of COVID19 Pfizer vaccine at 1103 am on 2/19/21, was last seen at 1159, found around 1615 by kitchen staff who were serving dinner.
Erythema, tenderness surrounding vaccine site right thigh with itching noted on 4/13/05. Tread with PO Benadryl for itching.
A physician reported that a male patient in his forties received an injection of Flu Shield (2002-2003 Formula) on 10/30/02. When he received the injection, he immediately felt a burning sensation described as feeling like a hot poker. Within 3 days, his arm was throbbing and advanced to shoulder pain. As of 11/26/02, the patient had severe shoulder pain with limited range of motion, 45 degrees flexion and 45 degrees abduction. He has no cross body pain; however, he experiences knifelike pain in his anterior and top shoulder. The pain has gotten worse over time. This is 1 of 3 patients from this facility who developed pain at the injection site following administration of lot 4020029. The reporter noted that they suspected lot 4020029 was administered, but were not sure. This lot was the product in the office as of 11/29/02. See related HQ5549927NOV2002 and HQ550627NOV2002.
This spontaneous report as received from the health care worker refers to a patient of unknown age and gender. No pertinent medical history and concurrent conditions reported. On 10-NOV-2015 the patient was vaccinated with improperly stored PNEUMOVAX 23, lot# L013248, expire date 03-FEB-2017, (dose number, frequency, route not reported). No adverse events reported. This is one of several reports received from the same reporter. Additional information has been requested.
Throat tightening, dizziness. Gave 50 mg of Benadryl
Information has been received from a RN concerning a 73 year old retired white female with no medical history who on 06/17/03 at 8:30 was vaccinated IM in the left deltoid with the second dose of pneumococcal 23v polysaccharide vaccine (Lot # 641804/0035M). Concomitant vaccinations on that same day and time included and ID dose in the left forearm of tuberculin purified protein derivative (PPD Tine Test) (Lot # 0042). Other concomitant therapy included, verapamil, hydrochlorothiazide (manufacturer unknown), omeprazole (Prilosec), alendronate sodium, thyroid (armour thyroid tablets), multivitamins (unspecified) and cetirizine HC1 (Zyrtec). There was no illness at the time of vaccination. The RN reported that on 09/17/03, the pt was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine that had expired on 08/16/03.  The RN also reported that on 09/18/03, the pt developed soreness at the injection site. Unspecified medical attention was sought and no lab/diagnostic tests were performed. On 09/19/03, the pt recovered from the injection site soreness.  Additional information is not expected.
potential invalid doses administered; vials are not frozen but already thawed upon receipt, clinic staff have been placing vials from those shipments into the refrigerator.; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a physician and describes the occurrence of WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (potential invalid doses administered) and MANUFACTURING PRODUCT SHIPPING ISSUE (vials are not frozen but already thawed upon receipt, clinic staff have been placing vials from those shipments into the refrigerator.) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (potential invalid doses administered) and MANUFACTURING PRODUCT SHIPPING ISSUE (vials are not frozen but already thawed upon receipt, clinic staff have been placing vials from those shipments into the refrigerator.). At the time of the report, WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (potential invalid doses administered) and MANUFACTURING PRODUCT SHIPPING ISSUE (vials are not frozen but already thawed upon receipt, clinic staff have been placing vials from those shipments into the refrigerator.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD21-083735. (Patient Link).
This spontaneous report was received from a physician referring to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions/allergies and concurrent conditions were not reported. On 04-DEC-2017, the patient was vaccinated with an improperly stored dose of VARIVAX lot # N015477 with expiration date 18-MAY-2019, for prophylaxis (dose and route of administration were not reported). Concomitant therapies included sterile diluent(STERILE DILUENT) which was properly stored. No adverse effects were reported. It was stated that the vaccine was exposed to a temperature between 15 to 46 Fahrenheit degrees with a time frame of 63 hours. No previous temperature excursion was reported. This is one of several reports from the same reporter.; Sender's Comments: US-009507513-1712USA002726: US-009507513-1801USA001109:
Beginning the day after my vaccine, I experienced a fever of 101.8, dizziness, extreme muscle pain, extreme skin sensitivity,  extreme headache, jaw pain (unable to chew), extremely tired. Every part of my body hurt.  24 hours after injection, I took 1,000MG of Tylenol and had some relief within 2 hours. The following day, I  had a temp of 99.8, continued on the Tylenol and experienced tiredness and dizziness. 24 hours later, I was completely better.
Difficulty breathing, weakness, fast heart beat, crying saying I am hurting in my heart area. 12/29/09 ER record received for date 10/21/09. DX: chest pain. Pt presented w/ SX: chest pain. Pt states difficulty catching breath. Pt parent states had fever x24hrs prev. w/ URI sx. Assessment: mild resp distress, tachycardia, (+)murmur, (+)epigastric pain.
Data exchange was not properly working in EHR. Office procedure did not include reconciliation of immunizations (only GRITS) causing an extra dose to be given.